RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,082 | +10.2% | 86,187 | +31.7% | 0.02% | -20.0% |
| Q2 2023 | $84,445 | +246.5% | 65,461 | +254.6% | 0.02% | +212.5% |
| Q1 2023 | $24,369 | -26.7% | 18,461 | -16.7% | 0.01% | -27.3% |
| Q4 2022 | $33,240 | +269.3% | 22,160 | +177.9% | 0.01% | +83.3% |
| Q2 2022 | $9,000 | -71.0% | 7,975 | -23.6% | 0.01% | -62.5% |
| Q1 2022 | $31,000 | +29.2% | 10,433 | +16.0% | 0.02% | +45.5% |
| Q4 2021 | $24,000 | +71.4% | 8,993 | +125.3% | 0.01% | +22.2% |
| Q3 2021 | $14,000 | +75.0% | 3,992 | +127.9% | 0.01% | +80.0% |
| Q2 2021 | $8,000 | – | 1,752 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |